drugset / Trial / NCT01634321

The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty

NCT01634321

Phase 4 Completed 63 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this Clinical Trial was to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide acetate 3.75mg) in patients with precocious puberty.

Timeline

Start
2011-07
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Leuprolide Other / unclassified 3.75 mg